Silencing of KCNIP3 enhances the epithelial–mesenchymal transition and proliferation via activating the Wnt/β-catenin pathway in papillary thyroid carcinoma [23]. This evidence concerns the gene KCNIP3 and differentiated thyroid carcinoma.